Vigilant BioSciences Continues its Partnership with Zer0 to 5ive in 2017
Vigilant Biosciences has renewed its contract with Zer0 to 5ive for public relations and marketing services in 2017 to support its OncAlert Oral Cancer and OncAlert Labs product lines in the U.S. and globally.
Finxact Partners with Zer0 to 5ive for Strategic Marketing Initiatives
Finxact, a visionary provider of core banking software-as-a-service, has chosen Zer0 to 5ive to build its brand through messaging, branding, and website design and development.
Zer0 to 5ive Launches OncAlert Website
Vigilant Biosciences® partnered with Zer0 to 5ive to design and develop a new website dedicated exclusively to the Company’s OncAlert® Oral Cancer product line, which includes the OncAlert Oral Cancer RAPID Test and the OncAlert Oral Cancer LAB Test. These tests detect CD44 and total protein – markers clinically validated to be associated specifically with oral cancer. The test results, along with other clinical factors, can aid in the early diagnosis of oral cancer. The launch of the OncAlert website coincides with the first shipment of the product line, which is now available in select countries.
Zer0 to 5ive Selected by The National Museum of Bermuda For Creation of an Ad Campaign
After building an award-winning website together, The National Museum of Bermuda decided to enlist the help of Zer0 to 5ive to conceptualize, design, and launch a new ad campaign. The ads will launch leading up to and during the 35th Americas World Cup, hosted in Bermuda in Spring of 2017. Zer0 to 5ive will be producing a series of both digital and print advertisements encouraging visitors of Bermuda to come to the museum and promoting its various exhibits and artifacts.
Crunchbase Engages Zer0 to 5ive to Develop Its Annual Report
Crunchbase has selected Zer0 to 5ive to design its year-end global innovation investment report and corresponding gated landing page. The report featured insights from the Crunchbase dataset with tables and graphs to visualize the data.
Zer0 to 5ive Chosen for NTT DOCOMO Positioning
NTT DOCOMO USA, Inc. a public company that has the largest market share in Japan for consumer mobile communications services, requested Zer0 to 5ive assist in updating its messaging on both its US services and business model, as well as the creation of a corresponding new sales capability presentation.
Ehrhardt + Partner Selects Zer0 to 5ive for North American Launch Support
Zer0 to 5ive has been selected to support the North American launch of Ehrhardt + Partner’s LFS warehouse management solution. Zer0 to 5ive will be assisting with its development of North America positioning and message and go-to-market plan.
Zer0 to 5ive Honored With Four Silver Davey Awards
We are proud to announce that Zer0 to 5ive has been awarded four silver Davey awards for its work in 2016. The winners include the Crunchbase corporate website, the Cloudmine website, cloumineinc.com, the National Museum of Bermuda website, and the PACT website. The Davey is an international award focused exclusively on honoring outstanding creative work from the best small agencies worldwide. The 2016 Davey Awards received nearly 4,000 entries from ad agencies, interactive agencies, production firms, in-house creative professionals, graphic designers, design firms and public relations firms. The Davey Awards is judged and overseen by the Academy of Interactive and Visual Arts (AIVA), a 700+ member organization of leading professionals from various disciplines of the visual arts dedicated to embracing progress and the evolving nature of traditional and interactive media.
Zer0 to 5ive Receives TWO 2016 W³ Awards
Zer0 to 5ive was honored with two W3 website awards for The National Museum of Bermuda and Cloudmine website design and development projects. The W3 Awards, which honor outstanding websites, web marketing, web video, mobile sites/apps and social content, received over 5000 entries for the 2016 awards.
PhotoSonix Medical Selects Zer0 to 5ive for Research and Go-to-Market Plan
PhotoSonix Medical has tapped Zer0 to 5ive to perform a research study and develop a go-to-market plan for its investigational device Clens which will potentially be deployed in the acne market.